In a historic building in Deep Ellum, a colossal effort is underway to bring some of the most famously extinct animals back to life. The wild mission comes from a Dallas-based company called Colossal Biosciences which is working to de-extinct the woolly mammoth, lost 4,000 years ago. Read more...
Read MoreERUSALEM & BANGKOK–(BUSINESS WIRE)–OurCrowd, a leading global digital investment platform, and RISE, the corporate innovation powerhouse based out of Southeast Asia, today announced the launch of the ROCX (Rise OurCrowd Exponential) Fund. The $50 million fund is Thailand’s first Israel-focused VC fund and will invest in early-stage deep technologies in cybersecurity, AI, HealthTech, semiconductors, quantum computing, ClimateTech, AgTech, FoodTech, and more. Read more here....
Read MoreFuture Ocean Foods debuts today as the world’s first alternative seafood association, dedicated to propelling the alt seafood industry into a new era. With an impressive list of inaugural memberships, the alliance already has 36 companies on board, spanning 14 countries. 40% of its members are women founders, and this percentage is set to increase. Read more...
Read MoreEMERYVILLE, Calif., Nov. 13, 2023 /PRNewswire/ — Eko Health, Inc. (Eko), a leader in AI technology for heart and lung disease detection, today unveiled new clinical data at the 2023 American Heart Association Scientific Sessions. This data demonstrated the real-world clinical efficacy of Eko’s AI-enabled SENSORA™ Platform to quickly and accurately detect structural murmurs associated with valvular heart disease. Valvular heart disease (VHD) is a medical condition present in over 50% of adults over the age of 65. VHD can lead to heart failure, stroke, and death, and if left undetected and untreated, can progress from moderate to severe within one year. Unfortunately, symptoms of VHD are frequently nonspecific, and more than half of patients with moderate to severe disease are asymptomatic, making VHD challenging to detect with conventional medical practice. Read...
Read MoreNEW YORK, Nov. 13, 2023 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Company”), a leader in the global digital health market, announced new research presented at the Diabetes Technology Society 2023 Meeting on November 7, 2023. The new research demonstrated the value of associating physical activity tracking alongside blood sugar tracking for people living with diabetes and pre-diabetes. Read more...
Read More
